Fast and pH-dependent release of domperidone from orally disintegrating tablets

References

• Ahmad N, Keith-Ferris J, Gooden E, Abell T. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol 2006;6:571–576.
   PubMed Web of Science ®Google Scholar
• Faassen F, Vogel G, Spanings H, Vromans H. Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm 2003;263:113–122.
   PubMed Web of Science ®Google Scholar
• Barone JA. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 1999;33:429–440.
   PubMed Web of Science ®Google Scholar
• Dobetti L. Fast-melting tablets: developments and technologies. Pharm Tech 2000;12:32–42.
   Google Scholar
• Sugibayashi K, Ito M, Miwa N, Makimura M, Kobayashi D, Yamaguchi M, Inoue N, Itobe H, Kimura M. Utility of prescription information to screen drug candidates suitable for orally disintegrating tablets. J Pharm Sci Tech Japan 2000;60:166–174.
   Google Scholar
• Parmar RB, Baria AH, Tank HM, Faldu SD. Formulation and evaluation of domperidone fast dissolving tablets. Int J of PharmTech Res 2009;1:483–487
   Google Scholar
• Singh SK, Mishra DN, Jassal R, Soni P. Fast disintegrating combination tablets of omeprazole and domperidone. Asian J Pharm Clin Res 2009;2:74–82.
   Google Scholar
• Corveleyn S, Remon JP. Bioavailability of hydrochlorothiazide: conventional versus freeze-dried tablets. Int J Pharm 1998;173:149–155.
   Web of Science ®Google Scholar
• Aly AM, Semreen M, Qato MK. Superdisintegrants for solid dispersion to produce rapidly disintegrating tenoxicam tablets via camphor sublimation. Pharm Tech 2005;29:68–79.
   Google Scholar
• Sugimoto M, Maejima T, Narisawa S, Matsubara K, Yoshino H. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose. Int J Pharm 2005;296:64–72.
   PubMed Web of Science ®Google Scholar
• Chang RK, Guo X, Burnside BA, Couch RA. Fast-dissolving tablets. Pharm Tech 2000;24:52–58.
   Google Scholar
• Koizumi K, Watanabe Y, Morita K, Utoguchi N, Matsumoto M. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm 1997;152:127–131.
   Web of Science ®Google Scholar
• Mishra DN, Bindal M, Singh SK, Vijaya Kumar SG. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull 2006;54:99–102.
   PubMed Web of Science ®Google Scholar
• Kristjansson TE. Rapidly disintegrating dosage form comprising magnesium carbonate heavy. 2006. WO Patent WO/2006/092812.
   Google Scholar
• Shu T, Suzuki H, Hironaka K, Ito K. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull 2002;50:193–198.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Nakano Y, Morimoto S, Tabata T, Hamaguchi N, Igari Y. Formulation study for lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior. Chem Pharm Bull 2003;51:942–947.
   PubMed Web of Science ®Google Scholar
• Perissutti B, Rubessa F, Moneghini M, Voinovich D. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Int J Pharm 2003;256:53–63.
   PubMed Web of Science ®Google Scholar
• Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. j Pharm Pharmacol 1998;50:375–382.
   PubMed Web of Science ®Google Scholar
• Laitinen R, Suihko E, Toukola K, Björkqvist M, Riikonen J, Lehto VP et al. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization. Eur J Pharm Biopharm 2009;71:271–281.
   PubMed Web of Science ®Google Scholar
• Tatavarti AS, Hoag SW. Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. J Pharm Sci 2006;95:1459–1468.
   PubMed Web of Science ®Google Scholar
• Takka S. Propranolol hydrochloride-anionic polymer binding interaction. Farmaco 2003;58:1051–1056.
   PubMedGoogle Scholar
• Tatavarti AS, Mehta KA, Augsburger LL, Hoag SW. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J Pharm Sci 2004;93:2319–2331.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. eds. Handbook of pharmaceutical excipients (5th edn). London: Pharmaceutical Press APhA, 2005:188.
   Google Scholar
• Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002;122:188–198.
   Web of Science ®Google Scholar
• British Pharmacopoeia. 2007.
   Google Scholar
• Mansur CRE, Monteiro EEC. Characterization of methacrylic polymers by calorimetry and infrared analyses. J Appl Polym Sci 1998;68:345–354.
   Google Scholar
• Orally disintegarting tablets, Guidance for Industry, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), [Online] December 2008. Available at: http://www.fda.gov/cder/guidance/index.htm. Accessed on 2 April 2010.
   Google Scholar
• Balasubramaniam J, Bindu K, Rao VU, Ray D, Haldar R, Brzeczko AW. Effect of superdisintegrants on dissolution of cationic drugs. Dissolution Technol 2008;15:18–25.
   Web of Science ®Google Scholar
• Balasubramaniam J, Bee T. Influence of superdisintegrants on the rate of drug dissolution from oral solid dosage forms. Pharm Tech [Online] April 2009. Available at: http://pharmtech.findpharma.com/pharmtech/article/articleDetail.jsp?id = 590450&pageID = 1&sk=&date=. Accessed on 22 March 2011.
   Google Scholar